A multi-center, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma.
Haematologica
; 2024 Aug 15.
Article
in En
| MEDLINE
| ID: mdl-39157871
ABSTRACT
Not available.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Haematologica
Year:
2024
Type:
Article